PF-Atlas › Clinical Trials › NCT05983471

Efficacy and Safety of ME-015 in Cough Related to Idiopathic Pulmonary Fibrosis

ME-015 · Phase 2

Registry ID

NCT05983471

Phase

Phase 2

Status

Active, not recruiting

Drug / intervention

ME-015 (Suplatast Tosilate)

Sponsor

Melius Pharma AB

Start

2024-04-01

About this trial

ME-015 is evaluated in NCT05983471, a Phase 2 idiopathic pulmonary fibrosis study sponsored by Melius Pharma AB. Current status: Active, not recruiting.

View NCT05983471 on ClinicalTrials.gov →

Explore related

All ME-015 trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT05983471 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.